Martigny, Switzerland

Robert Lysek

This inventor holds 1 USPTO granted patent. Top assignee: Debio Recherche Pharmaceutique S.a.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Lysek. Retrieved from https://idiyas.com/inventor/robert-lysek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Biography of Inventor Robert Lysek

Introduction: Robert Lysek is a notable inventor based in Martigny, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antiviral agents.

Latest Patents: Robert Lysek holds a patent for "Cycloundecadepsipeptide compounds and use of said compounds as a medicament." This invention relates to new cycloundecadepsipeptide compounds and their application as antiviral agents, specifically for preventing or treating Hepatitis C infections or HCV induced disorders.

Career Highlights: Robert Lysek is associated with Debio Recherche Pharmaceutique S.A., where he has been instrumental in advancing research in pharmaceutical sciences. His work focuses on innovative solutions for complex medical challenges.

Collaborations: Throughout his career, Robert has collaborated with esteemed colleagues, including Roland M Wenger and Manfred Mutter. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion: Robert Lysek's contributions to the field of medicinal chemistry and his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to impact the fight against viral infections, showcasing the importance of research and innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…